Adverse left ventricular remodelling after acute myocardial infarction: Is there a simple treatment that really works?

European Heart Journal

Volumn 35, Issue 3, 2014, Pages 144-146

  Muhlestein, Joseph B ^a  

^a INTERMOUNTAIN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; ATRIAL NATRIURETIC FACTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; COLLAGEN; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXYCYCLINE; GELATINASE A; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NEUROHORMONE; NICORANDIL; NITROPRUSSIDE SODIUM; PLACEBO; RENIN INHIBITOR;

ACUTE HEART INFARCTION; ADVERSE OUTCOME; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; CONGESTIVE HEART FAILURE; EDITORIAL; EXTRACELLULAR MATRIX; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE REMODELLING; HEART MUSCLE NECROSIS; HUMAN; INFLAMMATION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STEM CELL TRANSPLANTATION;

CARDIOTONIC AGENTS; DOXYCYCLINE; FEMALE; HUMANS; MALE; MYOCARDIAL INFARCTION; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84892746014     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/eht505     Document Type: Editorial

References (15)

1. AHA Heart Disease and Stroke 2013 Statistical Update. Circulation 2012;125: e2-e220.
2. McKay RG, Pfeffer MA, Pasternak RC, Markis JE, Come PC, Nakao S, Alderman JD, Ferguson JJ, Safian RD, Grossman W. Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion. Circulation 1986;74:693-702.
3. Sutton MG, Sharpe N. Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation 2000;101:2981-2988.
4. González A, Ravassa S, Beaumont J, López B, Díez J. New targets to treat the structural remodeling of the myocardium. J Am Coll Cardiol 2011;58:1833-1843.
5. Ishii H, Amano T, Matsubara T, Murohara T. Pharmacological intervention for prevention of left ventricular remodeling and improving prognosis in myocardial infarction. Circulation 2008;118:2710-2718.
6. Jeevanantham V, Butler M, Saad A, Abdel-Latif A, Zuba-Surma EK, Dawn B. Adult bone marrow cell therapy improves survival and induces long-term improvementin cardiac parameters: a systematic review and meta-analysis. Circulation 2012;126:551-568.
7. Cerisano G, Buonamici P, Valenti R, Sciagrà R, Raspanti S, Santini A, Carrabba N, Dovellini EV, Romito R, Pupi A, Colonna P, Antoniucci D. Early short-term doxycyc-line therapy in patients with acute myocardial infarction and left ventricular dysfunction to prevent the ominous progression to adverse remodelling: the TIPTOP trial. Eur Heart J 2014;35:184-191.
8. Lindsey ML, Zamilpa R. Temporal and spatial expression of matrix metalloprotei-nases and tissue inhibitors of metalloproteinases following myocardial infarction. Cardiovasc Ther 2012;30:31-41.
9. Sawicki G, Leon H, Sawicka J, Sariahmetoglu M, Schulze CJ, Scott PG, Szczesna-Cordary D, Schulz R. Degradation of myosin light chain in isolated rat hearts subjected to ischemia-reperfusion injury: a new intracellular target for matrix metalloproteinase-2. Circulation 2005;112:544-552.
10. Rizzi EL, Castro MM, Prado CM, Silva CA, Fazan R, Rossi MA, Tanus-Santos JE, Gerlach RF. Matrix metalloproteinase inhibition improves cardiac dysfunction and remodeling in 2-kidney, 1-clip hypertension. J Cardiac Fail 2010;16:599-608.
11. Smith K, Leyden JJ. Safety of doxycycline and minocycline: a systematic review. Clin Ther 2005;27:1329-1342.
12. Newby AC. Matrix metalloproteinase inhibition therapy for vascular diseases. Vascul Pharmacol 2012;56:232-244.
13. Caton J, Ryan ME. Clinical studies on the management of periodontal diseases utilizing subantimicrobial dose doxycycline (SDD). Pharmacol Res 2011;63: 114-120.
14. Iwasaka T, Takahashi N, Nakamura S, Sugiura T, Tarumi N, Kimura Y, Okubo N, Taniguchi H, Matsui Y, Inada M. Residual left ventricular pump function after acute myocardial infarction in NIDDM patients. Diabetes Care 1992;15:1522-1526.
15. Fong IW. Antibiotics effects in a rabbit model of Chlamydia pneumoniae-induced atherosclerosis. J Infect Dis 2000;181(Suppl 3):S514-S518.